NCT05741437

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150 in Healthy Adults

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-378

Detailed description

A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety after Oral Administration of CKD-378 and Co-administration of D745, D150 in Healthy Adults

Conditions

• Type II Diabetes

Interventions

Type	Name	Description
DRUG	CKD-378, QD, PO Drug: D745, D150, QD, PO	Durg: CKD-378, QD, PO Drug: D745, D150, QD, PO

Timeline

• Start date: 2023-04-11
• Primary completion: 2023-08-31
• Completion: 2023-09-05
• First posted: 2023-02-23
• Last updated: 2024-03-12

Locations

1 site across 1 country: South Korea